Original interpretation, not an aggregator
Modern Dosing explains what changes for medspa owners and RNs, what the evidence supports and what remains unresolved. Competitor publications are context, not product templates. Source links substantiate analysis; links are not the product.
What this version contains
40 source-linked reporting records and 377 source dossiers, plus seven monitoring profiles. Dossiers are not 377 independently verified public articles. No page count is used as a proxy for evidence quality. The 300–400-page editorial ambition is not a claim that all those pages have passed review.
One-year review
Window: 29 October 2025–29 October 2026. The inherited research used targeted month-by-month searches of FDA, HHS/Federal Register, MHRA, EMA, PubMed and sponsor releases. It is not an exhaustive archive export. Source publication, event and observation dates are distinct. Sponsor releases are not independent full-paper review. The annual evidence audit identifies the new original-source work and corpus counts; this expansion did not re-audit all inherited findings.
Provider evidence
The owner-supplied 377-row CSV retains every source field and label. “Verified,” “read,” “partial,” “snapshot,” “not_found” and “blocked” are inherited dataset assessments, not new quality certifications. Company claims establish what a company says, not clinical benefit, current active licensure or actual patient fulfillment. Search indexing is held for these source dossiers pending review.
Independent update pipeline
This standalone site has its own GitHub Actions collector, independent of Wabi. It is configured to run daily at 15:00 UTC and can be triggered manually. It checks a public PubMed query and a rotating sample of source URLs for new items or changed bytes. The collector opens a pull request containing an editorial queue and a coverage log. It cannot publish an article or upgrade evidence labels. Failed sources are recorded, not silently treated as unchanged. The schedule only runs once the workflow is enabled and GitHub permits its pull-request writes. No successful scheduled production run is claimed yet.
Editorial gate
An editor must inspect the original documents, dates, population, comparator, jurisdiction, commercial conflicts and uncertainty, then add accepted source-linked reporting. Clinical or legal conclusions require qualified review. Merging the reviewed content triggers Netlify’s normal Git deployment after connection. No AI-generated auto-publication is enabled.
Social sources & updates
The daily collector checks each listed public profile and identity/context URL for availability and changed bytes. It records source dates, failures and candidates in the editorial queue; it does not silently refresh profiles, certify identities or publish posts. No authorized X or Instagram API is connected. Complete feeds, historical searches, reliable engagement trends and credential validation are not running. Public pages may block collection or return a shared page shell; a successful request is not proof of current profile content. No platform-access circumvention is implemented.
Conflicts and independence
The publisher is developing Feel Peptides and related businesses, a potential commercial conflict. No paid placement or affiliate ranking is included. Research-use sellers are not recommended for human use. Content does not provide treatment protocols or individualized medical advice.
Corrections
Use Contact us to propose a correction, preserving the disputed claim, original source and date. Do not include patient information. Form delivery requires an active Netlify deployment with Forms enabled; repository issues remain available to authorized collaborators. No response deadline or clinical advice is offered.